tiprankstipranks
ALS Ltd. (CPBLF) was downgraded to a Hold Rating at Morgans
Blurbs

ALS Ltd. (CPBLF) was downgraded to a Hold Rating at Morgans

In a report released today, Tom Sartor from Morgans downgraded ALS Ltd. (CPBLFResearch Report) to a Hold, with a price target of A$13.70. The company’s shares closed last Tuesday at $7.93.

According to TipRanks, Sartor is ranked #633 out of 8749 analysts.

Currently, the analyst consensus on ALS Ltd. is a Moderate Buy with an average price target of $8.41, which is a 6.00% upside from current levels. In a report released on March 28, UBS also maintained a Hold rating on the stock with a A$13.30 price target.

Based on ALS Ltd.’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $25.2 billion and a GAAP net loss of $346 million. In comparison, last year the company earned a revenue of $21.79 billion and had a net profit of $1.12 billion

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ALS Ltd. (CPBLF) Company Description:

ALS Ltd. engages in the provision of technical services in the areas of testing, measurement and inspection, and supporting. It operates through the following segments: Life Sciences, Industrial, Commodities, and Other. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making decisions about environmental, food and pharmaceutical, electronics, and animal health testing matters. The Industrial segment focuses in asset care and tribology testing services to the energy, resources and infrastructure sectors. The Commodities segment involves in assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and gives specialist services to the coal industry such as coal sampling, analysis and certification, formation evaluation services, and related analytical testing. The company was founded in 1863 and is headquartered in Brisbane, Australia.

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles